DashboardAll companies
Run this on your own research
Healthcare · Drug Manufacturers - General

Otsuka Holdings Co., Ltd.

4578JPX¥12,455+¥60 (+0.48%)Market closed

Price Chart

Daily

Key facts

Market Cap
¥6.57T
P/E
18.2x
P/B
2.18x
ROE
12.6%

Otsuka Holdings Co., Ltd.

Healthcare · Drug Manufacturers - General · FY 2025

Otsuka Holdings Co., Ltd. is a diversified healthcare company predominantly engaged in pharmaceuticals and nutraceuticals. Its core mission is centered on innovation within the life sciences domain, emphasizing the development of treatments and healthcare products that improve human health and longevity. The company notably impacts the global pharmaceutical industry with a robust portfolio that includes medications for central nervous system disorders, cardiovascular conditions, and oncology treatments. Otsuka Holdings extends its influence into the consumer health sector through its nutraceutical line, offering functional foods and beverages designed to support overall wellness. Established in 2008 and headquartered in Tokyo, Japan, Otsuka Holdings serves a broad market that spans across North America, Europe, and Asia, contributing significantly to medical advancements and health improvements worldwide.

CEO
Mr. Makoto Inoue
Employees
35,338
Website
otsuka.com

Company Statistics

Valuation

P/E
18.2x
P/B
2.18x
P/S
2.67x
EV/EBITDA
10.0x
P/FCF
25.2x

Margins

Gross
71.7%
EBITDA
25.8%
Operating
19.1%
Pre-Tax
19.0%
Net
14.8%

Returns

ROA
9.2%
ROE
12.6%
ROIC
12.5%

Growth (CAGR)

Rev 3Yr
12.4%
Rev 5Yr
11.7%
Op Inc 3Yr
36.4%
Net Inc 3Yr
38.7%

Financial Health

Cash & Cash Equivalents
¥534.65B
Net Debt
¥563.16B
Debt/Equity
35.4%
Interest Cov
—

Profile

Revenue
¥2.47T
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Otsuka Holdings Co., Ltd. (4578) Stock Forecast 2026 ¥12,455 — Price, Financials & Analyst Targets | AlphaLenz